Pharmafile Logo
Pharmafocus logo
Advanced Search

Sanofi

Showing 15 posts of 579 posts found.

Sanofi image

Sanofi pays $700m to expand rare disease portfolio

January 13, 2014
Research and Development, Sales and Marketing Alnylam, Sanofi, rare sidease

Sanofi and Alnylam have announced the expansion of their 2012 agreement to develop and sell treatments for rare genetic diseases. …

News
GSK image

GSK and Sanofi expand transparency

January 6, 2014
Research and Development, Sales and Marketing GSK, Goldacre, Sanofi, alltrials, transparency

GlaxoSmithKline and Sanofi have announced separate moves which will shine greater light on both companies’ clinical trial data. GSK has …

News
sanofi_building

Sanofi hit hard by Lemtrada rejection

January 2, 2014
Medical Communications, Research and Development, Sales and Marketing Aubagio, FDA, Genzyme, Lemtrada, MS, Sanofi

News
sanofi image

Sanofi escapes most serious censure

December 13, 2013
Medical Communications, Sales and Marketing ABPI, Lyxumia, PMCPA, Sanofi, censure

Sanofi has been cleared of the most serious breach of the ABPI Code of Practice – despite appearing to offer …

News
Sanofi image

Priority review for Gaucher drug

December 12, 2013
Sales and Marketing EMA, FDA, Gaucher, Genzyme, Sanofi

The FDA is to conduct a speedy investigation into Sanofi’s twice-daily oral candidate for Gaucher disease, which means that Cerdelga …

News
NICE image

NICE wants more Lemtrada data

December 6, 2013
Sales and Marketing Lemtrada, MS, NICE, Sanofi

NICE has said there are ‘still questions to be answered’ over Sanofi’s submission of its multiple sclerosis drug Lemtrada and …

News
Sanofi image

New insulin scores for Sanofi

December 5, 2013
Research and Development, Sales and Marketing Lantus, Sanofi, diabetes, u300

Sanofi has been cheered after late-stage results from its investigational insulin U300 showed that the product may have advantages over …

News
sanofi image

Third failure for Sanofi/Merrimack cancer drug

November 27, 2013
Research and Development, Sales and Marketing Cancer, Sanofi, merrimack, mm-121

Sanofi and partner Merrimack have posted yet more disappointing results for their investigational cancer medicine MM-121. In the latest study …

News
Sanofi image

Sanofi discards blood cancer drug in late-stage

November 19, 2013
Research and Development, Sales and Marketing Sanofi, Wernicke's encephalopathy, fedratinib

Sanofi has scrapped its regulatory filing plans and late-stage trials for rare bone marrow cancer treatment fedratinib. The reason given …

News
Contrave image

Sanofi to produce weight-loss drug for Orexigen

November 11, 2013
Manufacturing and Production, Sales and Marketing Contrave, FDA, Sanofi, orexigen

Sanofi has agreed a deal to manufacture Orexigen Therapeutics’ weight-loss candidate Contrave outside North America. Under the commercial supply agreement, …

News
Genzyme image

‘Fatal’ safety concerns throw doubt on Lemtrada

November 11, 2013
Research and Development, Sales and Marketing FDA, Genzyme, Lemtrada, MS, Sanofi

An FDA committee has dashed hopes of an approval for Sanofi’s multiple sclerosis drug after saying its benefits may not …

News
Sanofi image

Sanofi cuts earnings guidance despite return to sales growth

October 31, 2013
Sales and Marketing Sanofi, Viehbacher, vaccines

Sanofi cut its earnings guidance for 2013 after its third quarter results missed targets, despite a return – barely – …

News
sanofi image

PMCPA: Sanofi ‘discredited pharma’

October 28, 2013
Medical Communications, Sales and Marketing ABPI, PMCPA, Sanofi, breach

Sanofi has lowered the public’s confidence in the pharma industry, according to the PMCPA, which enforces the ABPI Code of …

News
Monster manor image

Sanofi launches ‘Monster Manor’ diabetes app

October 23, 2013
Medical Communications Gamification, Sanofi, diabetes, monster manor

Sanofi has launched a new healthcare app called Monster Manor to help children with type 1 diabetes better manage their …

News
vincent_warnery_sanofi

Sanofi appoints senior vice president

October 10, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, warnery

Vincent Warnery has been appointed as the senior vice president to Sanofi’s new Global Consumer Healthcare Division. He will remain …

Appointment
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026